NC moves closer to approving bill that grants immunity to pharmaceutical companies if their products were approved by the FDA

About two weeks ago I reported (here) that the legislature in North Carolina was considering a bill that, subject to a few exceptions, would shield drug manufacturers from lawsuits by consumers if the product has been approved by a government agency. Today, Pharmalot is reporting that the North Carolina House Select Committee on Tort Reform voted to send the legislation to the full House for a vote, which may be held next week. Go here for the full story. You can read the draft of the bill here.